老虎證券

BUZZ-Capricor Therapeutics rises on meeting with US FDA for muscle disorder therapy

Reuters
2025/08/08
BUZZ-Capricor <a href="https://laohu8.com/S/LENZ">Therapeutics</a> rises on meeting with US FDA for muscle disorder therapy

** Shares of therapy developer Capricor Therapeutics CAPR.O up 3.22% at $8.33 premarket

** Co says meeting with U.S. FDA has been scheduled to discuss regulatory path of its cell therapy for treatment of cardiomyopathy associated with Duchenne muscular dystrophy, which is type of muscle disorder

** To accommodate this meeting, co has rescheduled release of its Q2 results to August 11 from August 12

** FDA in July declined to approved Deramiocel, saying the therapy does not meet efficacy requirements and asked for more data

** Up to last close, stock down 41.5% YTD

(Reporting by Sriparna Roy in Bengaluru)

((Sriparna.Roy@thomsonreuters.com;))

應版權方要求，你需要登入查看該內容

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10